PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Geriatric and Diabetology Unit, Department of Internal Medicine, University of Pavia, Pavia, Italy.\', \'Internal Medicine Unit, University of Pavia and IRCCS Policlinico San Matteo, Pavia, Italy.\', \'Department of Biomedical, Clinical Sciences \'Luigi Sacco\', University of Milan, Milan, Italy.\', \'III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.\', \'International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC L. Sacco, Università Degli Studi di Milano, Milan, Italy. paolo.fiorina@childrens.harvard.edu.\', \'Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy. paolo.fiorina@childrens.harvard.edu.\', \'Division of Nephrology, Boston Children\'s Hospital, Harvard Medical School, Boston, MA, USA. paolo.fiorina@childrens.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00592-020-01539-z
?:doi
?:hasPublicationType
?:journal
  • Acta diabetologica
is ?:pmid of
?:pmid
?:pmid
  • 32506195
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.587
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all